Showing results (41-50 of 191) with videos related to

Sort By:
Pageof 20
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 24, 2018
Evaluation of a Test Dose Strategy for Pharmacokinetically-Guided Busulfan Dosing for Hematopoietic Stem Cell TransplantationJessica M Davis, Anastasia Ivanova, Yunro Chung, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 8, 2025
Predicting Tumor Antigens Using the LENS Workflow Through RAFTSteven P Vensko Ii, Dante Bortone, Benjamin G Vincent
Biorxiv : the Preprint Server for Biology|April 1, 2024
Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapyMostafa Yazdimamaghani, Oleg V Kolupaev, Chaemin Lim, et al.
Blood|October 5, 2006
Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipientsPatricia A Taylor, Michael J Ehrhardt, Matthew M Roforth, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 6, 2017
Targeting the Canonical Nuclear Factor-κB Pathway with a High-Potency IKK2 Inhibitor Improves Outcomes in a Mouse Model of Idiopathic Pneumonia SyndromeKenneth A Fowler, Corey M Jania, Stephen L Tilley, et al.
Biomaterials|August 10, 2024
Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapyMostafa Yazdimamaghani, Oleg V Kolupaev, Chaemin Lim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 27, 2012
Bone marrow B cell precursor number after allogeneic stem cell transplantation and GVHD developmentYuri Fedoriw, T Danielle Samulski, Allison M Deal, et al.
Blood|February 27, 2010
Separation of graft-versus-host disease from graft-versus-leukemia responses by targeting CC-chemokine receptor 7 on donor T cellsJames M Coghill, Michael J Carlson, Angela Panoskaltsis-Mortari, et al.
Blood Advances|October 7, 2021
Third-party type 2 innate lymphoid cells prevent and treat GI tract GvHDDanny W Bruce, Oleg Kolupaev, Sonia J Laurie, et al.
Blood|July 9, 2005
Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host diseaseChristian A Wysocki, Qi Jiang, Angela Panoskaltsis-Mortari, et al.
Pageof 20